(Q53266049)

12 May 2018

title

Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease. (English)

1 reference

12 May 2018

0 references

P N Wang

1

1 reference

12 May 2018

H C Liu

2

1 reference

12 May 2018

T Y Liu

3

1 reference

12 May 2018

A Chu

4

1 reference

12 May 2018

C J Hong

5

1 reference

12 May 2018

K N Lin

6

1 reference

12 May 2018

C W Chi

7

1 reference

12 May 2018

publication date

9 December 2004

1 reference

12 May 2018

Dementia and Geriatric Cognitive Disorders

published in

1 reference

12 May 2018

volume

19

1 reference

12 May 2018

issue

2-3

1 reference

12 May 2018

page(s)

120-125

1 reference

12 May 2018

Estrogen and neurodegeneration

cites work

1 reference

The neuroprotective effects of estrogen on the aging brain.

21 January 2018

1 reference

Are the estrogen receptors involved in Alzheimer's disease?

21 January 2018

1 reference

Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women.

21 January 2018

1 reference

Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia.

21 January 2018

1 reference

Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease.

21 January 2018

1 reference

Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women

21 January 2018

1 reference

Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism

21 January 2018

1 reference

Molecular mechanisms of estrogen carcinogenesis

21 January 2018

1 reference

Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view.

21 January 2018

1 reference

Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction

21 January 2018

1 reference

Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

21 January 2018

1 reference

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging

21 January 2018

1 reference

Endogenous estrogen levels and Alzheimer's disease among postmenopausal women.

21 January 2018

1 reference

Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women

21 January 2018

1 reference

Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease.

21 January 2018

1 reference

Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease

21 January 2018

1 reference

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

21 January 2018

1 reference

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to functional apolipoprotein e genotype

21 January 2018

1 reference

Age and sex-dependent decreases in ChAT in basal forebrain nuclei

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000082663

1 reference

12 May 2018

1 reference

12 May 2018